Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,728.04
1,761.11
1,613.21
1,775.29
1,553.20
1,268.21
1,080.87
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,728.04
1,761.11
1,613.21
1,775.29
1,553.20
1,268.21
1,080.87
Raw Material Cost
538.69
548.67
568.97
641.30
621.26
511.72
331.81
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
15.03
22.12
21.46
24.84
18.85
17.29
11.22
Selling and Distribution Expenses
728.65
821.71
775.59
920.70
751.83
608.05
621.67
Other Expenses
12.35
10.10
7.08
3.47
2.64
3.05
2.62
Total Expenditure (Excl Depreciation)
1,405.87
1,493.53
1,436.86
1,621.54
1,418.30
1,167.60
990.92
Operating Profit (PBDIT) excl Other Income
322.2
267.6
176.4
153.7
134.9
100.60000000000001
89.9
Other Income
62.74
85.30
69.32
215.27
0.91
20.79
39.66
Operating Profit (PBDIT)
453.35
409.35
312.47
444.12
214.83
191.49
177.87
Interest
15.03
22.12
21.46
24.84
18.85
17.29
11.22
Exceptional Items
0.91
-11.52
-2.38
0.19
-14.01
-6.06
-7.18
Gross Profit (PBDT)
1,189.35
1,212.44
1,044.24
1,133.99
931.95
756.48
749.05
Depreciation
86.69
84.85
81.11
88.12
89.72
79.68
56.50
Profit Before Tax
352.55
290.86
207.52
331.35
92.25
88.46
102.96
Tax
50.61
36.14
23.71
49.87
20.87
15.20
15.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
306.39
255.22
186.82
285.85
70.04
63.79
78.91
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
306.39
255.22
186.82
285.85
70.04
63.79
78.91
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-3.75
-5.37
-7.20
-9.15
-0.12
-10.02
0.06
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
302.64
249.85
179.62
276.71
69.92
53.78
78.97
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,711.68
1,622.97
1,458.09
1,390.12
1,196.04
1,151.74
1,126.91
Earnings per share (EPS)
0.7
0.58
0.42
0.67
0.16
0.15
0.18
Diluted Earnings per share
0.7
0.58
0.42
0.67
0.16
0.15
0.18
Operating Profit Margin (Excl OI)
17.59%
13.58%
10.04%
7.93%
8.0%
7.18%
7.56%
Gross Profit Margin
25.42%
21.33%
17.89%
23.63%
11.72%
13.26%
14.75%
PAT Margin
17.73%
14.49%
11.58%
16.1%
4.51%
5.03%
7.3%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -1.88% vs 9.17% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 21.14% vs 39.09% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 20.52% vs 33.32% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -32.13% vs 2.79% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Hunan Fangsheng Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,728.04
0
1,728.04
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,728.04
0
1,728.04
Raw Material Cost
538.69
0
538.69
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
15.03
0
15.03
Selling and Distribution Expenses
728.65
0
728.65
Other Expenses
12.35
0.00
12.35
Total Expenditure (Excl Depreciation)
1,405.87
0
1,405.87
Operating Profit (PBDIT) excl Other Income
322.17
0.00
322.17
Other Income
62.74
0
62.74
Operating Profit (PBDIT)
453.35
0
453.35
Interest
15.03
0
15.03
Exceptional Items
0.91
0
0.91
Gross Profit (PBDT)
1,189.35
0
1,189.35
Depreciation
86.69
0
86.69
Profit Before Tax
352.55
0
352.55
Tax
50.61
0
50.61
Provisions and contingencies
0
0
0.00
Profit After Tax
306.39
0
306.39
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
306.39
0
306.39
Share in Profit of Associates
0
0
0.00
Minority Interest
-3.75
0
-3.75
Other related items
0.00
0.00
0.00
Consolidated Net Profit
302.64
0
302.64
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,711.68
0
1,711.68
Earnings per share (EPS)
0.70
0
0.70
Diluted Earnings per share
0.70
0
0.70
Operating Profit Margin (Excl OI)
17.59%
0%
0.00
17.59%
Gross Profit Margin
25.42%
0%
0.00
25.42%
PAT Margin
17.73%
0%
0.00
17.73%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 172.80 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -1.88% vs 9.17% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 30.26 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 21.14% vs 39.09% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 39.06 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 20.52% vs 33.32% in Dec 2024
Annual - Interest
Interest 1.50 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -32.13% vs 2.79% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.59%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






